Logo

Whatariff.com

Global Tariffs, Categorized

🇺🇸 United States
🇦🇩 Andorra
📦 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified
🇺🇸 🇦🇩

United States to Andorra Trade Analysis for Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified

Detailed tariff information for Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified imports

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified Tariff Rate

HS Code:

0%
Effective January 1, 1993

Trade Volume

Value
Not specifically available for HS Code 3002 due to aggregated data reporting
Year
2023
Trend
Stable demand for medical and pharmaceutical products

Special Rates

Preferential Rate
0%
Applicable under the EU-Andorra Customs Union for medical and pharmaceutical products; requires proper documentation and compliance with health regulations.

Additional Information

No additional information available.
Last updated: 1 year ago

News and Updates

Recent News
No Recent Trade News on HS Code 3002 Between US and Andorra
There are no recent news articles or reports specifically addressing trade in human blood, blood fractions, vaccines, or related products (HS Code 3002) between the United States and Andorra. Trade in these products between the two countries appears to be minimal or undocumented in public sources.
N/A
Impact: No significant impact on trade due to lack of reported activity or developments.
General US Pharmaceutical Export Trends
The United States continues to be a leading exporter of pharmaceutical products, including vaccines and blood-related products under HS Code 3002, though specific data on trade with Andorra remains unavailable. Andorra's small market size likely limits significant bilateral trade in this category.
October 2023
Impact: Minimal relevance to US-Andorra trade; broader US export policies may indirectly influence availability of such products in smaller markets.
Andorra's Healthcare Import Dependency
Andorra, lacking significant domestic production of pharmaceuticals or biotechnological products, relies heavily on imports for medical supplies, including items under HS Code 3002. However, trade data and news specific to the United States as a source are not recently documented.
September 2023
Impact: Potential for US exporters to explore Andorra's market, though no direct trade impact reported recently.
Policy Updates
No Specific US-Andorra Trade Policy Updates for HS Code 3002
There are no recent policy updates or bilateral agreements between the United States and Andorra specifically addressing trade in human blood, vaccines, or related immunological products under HS Code 3002. General US export regulations and Andorra's import policies aligned with European standards apply.
Date: N/A